Supplement-Induced Thyrotoxicosis Presenting as New Onset Tachycardia

B. Ascherman, J. Schwartz, Z. Khan, M. Bachan
{"title":"Supplement-Induced Thyrotoxicosis Presenting as New Onset Tachycardia","authors":"B. Ascherman, J. Schwartz, Z. Khan, M. Bachan","doi":"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2990","DOIUrl":null,"url":null,"abstract":"INTRODUCTION: Dietary and herbal supplements can contain clinically significant amounts of exogenous thyroid stimulants and hormones, including T3 and T4, thus placing consumers at increased risk of thyrotoxicosis and other metabolic-related adverse effects. We present a case of thyrotoxicosis in a young man with no history of thyroid disease, who was found to be consuming an extensive variety of supplements. DESCRIPTION: A 31 year old man with hypertension presented with 1 week of intermittent palpitations. He was in his usual state of health until 1 week prior to admission, when he noticed intermittent, self-resolving episodes of tachycardia as high as the 160s on his smart watch, associated with palpitations, dyspnea, low grade fevers, and intermittent dry cough. He came to the ED for persistence of symptoms. In the ED: T 98.8 F, HR 129, BP 152/77, RR 18, SpO2 98% on RA. CBC, BMP, UA, UTox, blood alcohol content, troponin and COVID tests were unremarkable. TSH was < .007 [0.358-3.740 ulU/mL], with a free thyroxine of 0.54 [0.70-1.48 ng/dL];other thyroid studies later returned with TSI < 0.10 [0.00-0.55 IU/L], free T3 32.50 [1.80-4.60 pg/mL], and an unremarkable thyroid ultrasound. CXR showed no acute infiltrates. EKG revealed sinus tachycardia, no Wolff-Parkinson-White syndrome, and no Brugada waveforms. He was given 2L NS, ceftriaxone 1g IV, aspirin 81mg PO, and tylenol 650mg PO, and admitted to the telemetry unit. Exam revealed an anxious appearing man with tachycardia. On ROS, patient admitted to drinking 6-8 cups of coffee daily, and to taking at least a dozen different supplements. He was started on propranolol 30 mg every 6 hours with improvement in his heart rate, and was counseled to stop the supplements and wean his caffeine intake. He was discharged the following day with plan for endocrinology and primary care follow-up. DISCUSSION: Thyrotoxicosis in this young patient with no history of thyroid disease posed a diagnostic quandary. This prompted further investigation into a more detailed social history, which revealed the extensive variety of supplements he was taking, consistent with thyrotoxicosis factitia. In patients presenting with newonset tachycardia, our case highlights the importance of collecting a thorough social history and maintaining early suspicion for thyroid disease and thyrotoxicosis.","PeriodicalId":432295,"journal":{"name":"B48. OCCUPATIONAL AND EXPOSURE-RELATED CASE REPORTS","volume":"171 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"B48. OCCUPATIONAL AND EXPOSURE-RELATED CASE REPORTS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2990","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

INTRODUCTION: Dietary and herbal supplements can contain clinically significant amounts of exogenous thyroid stimulants and hormones, including T3 and T4, thus placing consumers at increased risk of thyrotoxicosis and other metabolic-related adverse effects. We present a case of thyrotoxicosis in a young man with no history of thyroid disease, who was found to be consuming an extensive variety of supplements. DESCRIPTION: A 31 year old man with hypertension presented with 1 week of intermittent palpitations. He was in his usual state of health until 1 week prior to admission, when he noticed intermittent, self-resolving episodes of tachycardia as high as the 160s on his smart watch, associated with palpitations, dyspnea, low grade fevers, and intermittent dry cough. He came to the ED for persistence of symptoms. In the ED: T 98.8 F, HR 129, BP 152/77, RR 18, SpO2 98% on RA. CBC, BMP, UA, UTox, blood alcohol content, troponin and COVID tests were unremarkable. TSH was < .007 [0.358-3.740 ulU/mL], with a free thyroxine of 0.54 [0.70-1.48 ng/dL];other thyroid studies later returned with TSI < 0.10 [0.00-0.55 IU/L], free T3 32.50 [1.80-4.60 pg/mL], and an unremarkable thyroid ultrasound. CXR showed no acute infiltrates. EKG revealed sinus tachycardia, no Wolff-Parkinson-White syndrome, and no Brugada waveforms. He was given 2L NS, ceftriaxone 1g IV, aspirin 81mg PO, and tylenol 650mg PO, and admitted to the telemetry unit. Exam revealed an anxious appearing man with tachycardia. On ROS, patient admitted to drinking 6-8 cups of coffee daily, and to taking at least a dozen different supplements. He was started on propranolol 30 mg every 6 hours with improvement in his heart rate, and was counseled to stop the supplements and wean his caffeine intake. He was discharged the following day with plan for endocrinology and primary care follow-up. DISCUSSION: Thyrotoxicosis in this young patient with no history of thyroid disease posed a diagnostic quandary. This prompted further investigation into a more detailed social history, which revealed the extensive variety of supplements he was taking, consistent with thyrotoxicosis factitia. In patients presenting with newonset tachycardia, our case highlights the importance of collecting a thorough social history and maintaining early suspicion for thyroid disease and thyrotoxicosis.
补充剂诱导的甲状腺毒症表现为新发心动过速
简介:膳食和草药补充剂可能含有临床显著量的外源性甲状腺兴奋剂和激素,包括T3和T4,从而使消费者面临甲状腺毒症和其他代谢相关不良反应的风险增加。我们提出一个甲状腺毒症的情况下,在一个年轻的男子没有甲状腺疾病的历史,谁被发现是消费广泛的各种补充剂。描述:一名31岁的高血压患者出现了1周的间歇性心悸。入院前1周,患者健康状况正常,智能手表显示间歇性、自解性心动过速高达160分,伴有心悸、呼吸困难、低烧和间歇性干咳。他因为症状持续而来急诊室。在ED: T 98.8 F, HR 129, BP 152/77, RR 18, SpO2 98%的RA。CBC、BMP、UA、UTox、血液酒精含量、肌钙蛋白和COVID检测均无显著差异。TSH < 0.008 [0.358-3.740 ulU/mL],游离甲状腺素为0.54 [0.70-1.48 ng/dL];后来其他甲状腺检查显示TSI < 0.10 [0.00-0.55 IU/L],游离T3 32.50 [1.80-4.60 pg/mL],甲状腺超声检查不明显。CXR未见急性浸润。心电图显示窦性心动过速,无Wolff-Parkinson-White综合征,无Brugada波形。患者给予ns2l,头孢曲松1g IV,阿司匹林81mg PO,泰诺650mg PO,并入住遥测病房。检查发现一名心急如火的男子,伴有心动过速。在ROS方面,患者承认每天喝6-8杯咖啡,并服用至少12种不同的补充剂。他开始每6小时服用30毫克心得安,心率有所改善,医生建议他停止服用补充剂,并戒掉咖啡因的摄入。患者于第二天出院,并计划进行内分泌科和初级保健随访。讨论:甲状腺毒症在这个年轻的患者没有甲状腺疾病的历史提出了诊断困境。这促使进一步调查更详细的社会历史,揭示了他正在服用各种各样的补充剂,符合功能性甲状腺毒症。在新发心动过速的患者中,我们的病例强调了收集完整的社会病史和保持对甲状腺疾病和甲状腺毒症的早期怀疑的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信